Summary
Treatment of phenylketonuria (PKU, OMIM 261600) means a diet restricted in natural protein and supplemented with phenylalanine (Phe)-free l-amino acid mixtures. Growth impairment has been described even in patients with a total protein intake at or above the recommended dietary allowance (RDA). In the present study, growth and body composition (fat-free mass (FFM) and fat) were recorded over 12 months in 34 treated PKU patients (mean age 8.7 years at baseline). Measurements were compared with those of healthy peers and with general population standard (Z-) scores calculated using the LMS method. In 28 PKU patients, data on birth weight and birth length were available and related to measurements at baseline of the study. Mean total protein intake in PKU patients was 124% (range 77–193%) of the RDA (DACH 2000). No significant differences in growth and body composition were present between PKU patients and healthy populations either at birth or during the study period. The significant correlation of FFM (representing muscle mass) with intake of natural protein—rather than total protein—indicates that the enhancement of tolerance to natural protein may be of value in PKU patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acosta PB, Yannicelli S, Marriage B, et al (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. JPGN: J Pediatr Gastroenterol Nutr 27: 287–291.
Acosta PB, Yannicelli S, Marriage B et al (1999) Protein status of infants with phenylketonuria undergoing nutrition management. J Am Coll Nutr 18: 102–107.
Acosta PB, Yannicelli S, Singh R, et al (2003) Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc 103: 1167–1173.
Allen JR, Baur LA, Waters DL, et al (1996) Body protein in prepubertal children with phenylketonuria. Eur J Clin Nutr 50: 178–186.
Arnold GL, Vladutiu CJ, Kirby RS, Blakely EM, DeLuca JM (2002) Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 141: 243–246.
Burgard P, Bremer HJ, Bührdel PM, et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr 158: 46–54.
Cole TJ (1990) The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44: 45–60.
DACH (2000) Referenzwerte für die Nährstoffzufuhr. Frankfurt: Umschau-Verlag.
Daenzer M, Petzke KJ, Bequette BJ, Metges CC (2001) Whole-body nitrogen and splanchnic amino acid metabolism differ in rats fed mixed diets containing casein or its corresponding amino acid mixture. J Nutr 131: 1965–1972.
de Bruin NC, van Velthoven KAM, de Ridder M, et al (1996) Standards for total body fat and fat-free mass in infants. Arch Dis Child 74: 386–399.
Dobbelaere D, Michaud L, Debrabander A, et al (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J Inherit Metab Dis 26: 1–11.
Hennermann JB, Buhrer C, Blau N, Vetter B, Mönch E (2005) Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol Genet Metab 86: S86–S90.
Herrmann ME, Brosicke HG, Keller M, Monch E, Helge H (1994) Dependence of the utilization of a phenylalanine-free amino acid mixture on different amounts of single dose ingested. A case report. Eur J Pediatr 153: 501–503.
Hoeksma M, van Rijn M, Verkerk PH, et al (2005) The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J Inherit Metab Dis 28: 845–854.
Holm VA, Kronmal RA, Williamson M, Roche AF (1979) Physical growth in phenylketonuria. II. Growth of treated children in the PKU Collaborative Study from birth to 4 years of age. Pediatrics 63: 700–707.
Ikeda K, Schiltz E, Fujii T, et al (2005) Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria. Amino Acids 29: 283–287.
Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al (2001) Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatschr Kinderheilk 149: 807–818.
McBurnie MA, Kronmal RA, Schuett VE, Koch R, Azeng CG (1991) Physical growth of children treated for phenylketonuria. Ann Hum Biol 18: 357–368.
Schäfer F, Burgard P, Batzler U, et al (1994) Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr 83: 534–541.
van der Schot LW, Doesburg WH, Sengers WCA (1994) The phenylalanine response curve in relation to growth and mental development in the first years of life. Acta Paediatr 407: 68–69.
Verkerk PH, van Spronsen FJ, Smit GPA, Sengers RCA (1994) Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. Arch Dis Child 71: 114–118.
White JE, Kronmal RA, Acosta PD (1982) Excess weight among children with phenylketonuria. J Am Coll Nutr 1: 293–303.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Nenad Blau
Competing interests: None declared
References to electronic databases: Phenylketonuria (PKU): OMIM 261600.
The Ethics committee of the University of Vienna approved the study. Patients gave informed consent for participation.
Rights and permissions
About this article
Cite this article
Huemer, M., Huemer, C., Möslinger, D. et al. Growth and body composition in children with classical phenylketonuria: Results in 34 patients and review of the literature. J Inherit Metab Dis 30, 694–699 (2007). https://doi.org/10.1007/s10545-007-0549-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-007-0549-3